Enhabit, Inc. Update: The "For Sale" Sign is Now a Done Deal

Here is the latest on Enhabit, Inc. (ticker: EHAB), a major provider of home health and hospice services. The company has officially moved from "exploring options" to a concrete plan to sell the business.

1. What happened?

Enhabit is being acquired. The company signed a deal to be bought by Anchor Parent, LLC, a firm backed by Kinderhook Industries. Enhabit shareholders will receive $14.50 per share in cash. This values the company at roughly $575 million, including its debt.

On April 15, 2026, the Federal Trade Commission cleared the deal, removing the primary legal hurdle and confirming the government sees no antitrust issues with the acquisition.

2. Why is this happening?

Enhabit operates over 250 locations across 34 states. Recently, it faced a "triple threat": rising labor costs, a shortage of skilled clinicians, and flat Medicare payments. In 2025, these costs grew faster than revenue, shrinking profit margins. Rather than continuing as a public company—which requires expensive compliance and scaling—the board decided a cash sale offers the best value for shareholders.

3. What does this mean for your investment?

For investors, the uncertainty is over. The company is now in the final closing phase. The stock price will likely stop reacting to market rumors and instead hover near the $14.50 buyout price. Any gap between the current price and $14.50 reflects the market’s view on whether the deal will successfully close.

4. What is changing behind the scenes?

Because the sale is nearly complete, Enhabit has made two major communication changes:

• No more earnings calls: The company canceled its Q1 2026 conference call. They will no longer hold public forums to discuss profits or operations.
• No more guidance: They withdrew all financial forecasts for 2026. As the company prepares to go private, its future public performance is no longer a priority.

5. What happens next?

The final step is the Special Meeting of Stockholders on May 12, 2026. Shareholders of record as of April 10, 2026, will vote to approve the merger. If a majority of shares vote "yes" and other conditions are met, the company expects to finish the sale in the second quarter of 2026.

6. Key takeaways for your decision

• The "Wait and See" game: The stock is no longer a growth play. It is now a "merger arbitrage" play, where the price depends entirely on the deal closing.
• Read the Proxy: Check the Definitive Proxy Statement filed on April 14, 2026. It details the bidding process and the financial analysis from the company’s bankers.
• Watch the calendar: Keep May 12, 2026, on your radar. If shareholders do not approve the deal, the stock price will likely drop significantly as the "deal premium" disappears.

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions.